These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37357849)

  • 1. Peptides as "better biomarkers"? Value, challenges, and potential solutions to facilitate implementation.
    Latosinska A; Frantzi M; Siwy J
    Mass Spectrom Rev; 2024; 43(6):1195-1236. PubMed ID: 37357849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of endogenous peptides using mass spectrometry based methods.
    Romanova EV; Dowd SE; Sweedler JV
    Curr Opin Chem Biol; 2013 Oct; 17(5):801-8. PubMed ID: 23790312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Peptidome Comes of Age: Mass Spectrometry-Based Characterization of the Circulating Cancer Peptidome.
    Greening DW; Kapp EA; Simpson RJ
    Enzymes; 2017; 42():27-64. PubMed ID: 29054270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization for Peptide Sample Preparation for Urine Peptidomics.
    Sigdel TK; Nicora CD; Qian WJ; Sarwal MM
    Methods Mol Biol; 2018; 1788():63-72. PubMed ID: 29623538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future.
    Latosinska A; Siwy J; Mischak H; Frantzi M
    Electrophoresis; 2019 Sep; 40(18-19):2294-2308. PubMed ID: 31054149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delineating protein biomarkers for gastric cancers: A catalogue of mass spectrometry-based markers and assessment of their suitability for targeted proteomics applications.
    Ramesh P; Nisar M; Neha ; Ammankallu S; Babu S; Nandakumar R; Abhinand CS; Prasad TSK; Codi JAK; Raju R
    J Proteomics; 2024 Aug; 306():105262. PubMed ID: 39047941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery from body fluids using mass spectrometry.
    Villar-Garea A; Griese M; Imhof A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of urinary proteomics/peptidomics.
    Albalat A; Mischak H; Mullen W
    Expert Rev Proteomics; 2011 Oct; 8(5):615-29. PubMed ID: 21999832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Proteomics: Closing the Gap from Discovery to Implementation.
    Frantzi M; Latosinska A; Kontostathi G; Mischak H
    Proteomics; 2018 Jul; 18(14):e1700463. PubMed ID: 29785737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.
    Azkargorta M; Soria J; Acera A; Iloro I; Elortza F
    J Proteomics; 2017 Jan; 150():359-367. PubMed ID: 27184738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry for the quantification of bioactive peptides in biological fluids.
    Tamvakopoulos C
    Mass Spectrom Rev; 2007; 26(3):389-402. PubMed ID: 17160998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of blood serum peptide enrichment methods by Tricine SDS-PAGE and mass spectrometry.
    Biosa G; Addis MF; Tanca A; Pisanu S; Roggio T; Uzzau S; Pagnozzi D
    J Proteomics; 2011 Dec; 75(1):93-9. PubMed ID: 21757041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric analysis of body fluids for biomarker discovery.
    Good DM; Coon JJ
    Methods Mol Biol; 2009; 566():277-91. PubMed ID: 20058178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying and Measuring Endogenous Peptides through Peptidomics.
    Checco JW
    ACS Chem Neurosci; 2023 Oct; 14(20):3728-3731. PubMed ID: 37751547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptidomics analysis of human blood specimens for biomarker discovery.
    Tammen H; Peck A; Budde P; Zucht HD
    Expert Rev Mol Diagn; 2007 Sep; 7(5):605-13. PubMed ID: 17892366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining the Biomarker Potential of the Urine Peptidome: From Amino Acids Properties to Proteases.
    Trindade F; Barros AS; Silva J; Vlahou A; Falcão-Pires I; Guedes S; Vitorino C; Ferreira R; Leite-Moreira A; Amado F; Vitorino R
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digging Deep into Peptidomics Applied to Body Fluids.
    Vitorino R
    Proteomics; 2018 Jan; 18(2):. PubMed ID: 29251826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics in Chronic Arthritis-Will We Finally Have Useful Biomarkers?
    Kessel C; McArdle A; Verweyen E; Weinhage T; Wittkowski H; Pennington SR; Foell D
    Curr Rheumatol Rep; 2018 Jul; 20(9):53. PubMed ID: 30008153
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.